DAWN GRIMM: Open Payments
NPI 1588157465 · LISLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 20 payments from 11 companies in 2025. Trend: 2023 $801 · 2024 $1,055 · 2025 $1,058
Long term medical supply or device loan: $598Food & beverage: $312Education: $148
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $655 |
| Gilead Sciences, Inc. | 2 | $97 |
| SEAGEN INC. | 1 | $74 |
| EMD Serono, Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $41 |
| Genentech USA, Inc. | 1 | $32 |
| TerSera Therapeutics LLC | 1 | $30 |
| PFIZER INC. | 1 | $29 |
| ABBVIE INC. | 1 | $22 |
| Incyte Corporation | 1 | $20 |
Products named: KISQALI, Trodelvy, Tecentriq, Fabhalta, Zoladex, IBRANCE, ELAHERE, MONJUVI.
Industry payments across IL — which companies pay providers there.
